Morphology and morphometry of Carpal tunnel
Project Description
Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation. Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.
Project Duration
2025 - Ongoing
Project Lead
Dr. Nachiket Shankar
Authors
Dr.Nachiket Shankar, Dr.Vijay Joseph, Dr.Yogitha R
Project Status
ongoing
Project Type
Dr.Nachiket Shankar